Article
Allergy
Katherine N. Cahill, Pingsheng Wu, Ginger L. Milne, Taneem Amin, Joseph Singer, Katherine Murphy, Erin Lewis, Deborah Gapko, Joshua A. Boyce, Katherine M. Buchheit, Tanya M. Laidlaw
Summary: There is a discrepancy between nasal and systemic levels of mast cell products in patients with aspirin-exacerbated respiratory disease, with systemically detected levels likely derived from mast cells outside of the sinonasal cavity. Increased body mass index decreases systemic mast cell mediator production and reaction severity.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
(2022)
Article
Chemistry, Analytical
Wenxi Xia, Shuangzhe Zhang, Jiangli Fan, Yueqing Li, Xiaojun Peng
Summary: A novel highly selective and sensitive green-emitting probe (APLN) containing a fluorophore, a linker, and a COX-2 kinase inhibitor (aspirin) has been designed and evaluated. This probe successfully labels the COX-2 enzyme to identify tumors and significantly inhibits tumor growth in a xenotransplantation model of nude mice, showing potential for in situ imaging and fluorescent-visible cancer therapy.
SENSORS AND ACTUATORS B-CHEMICAL
(2021)
Article
Immunology
Kehong Zhang, Paul Mike Jordan, Simona Pace, Robert K. Hofstetter, Markus Werner, Xinchun Chen, Oliver Werz
Summary: This study found that Celastrol (CS), a major active ingredient in the herb Tripterygium wilfordii, can positively impact macrophage activity by regulating lipoxygenase activities and the expression of LM-biosynthetic enzymes, leading to changes in inflammation-related lipid mediators.
JOURNAL OF INFLAMMATION RESEARCH
(2022)
Article
Chemistry, Multidisciplinary
Friedemann Boerner, Simona Pace, Paul M. Jordan, Jana Gerstmeier, Mario Gomez, Antonietta Rossi, Nathaniel C. Gilbert, Marcia E. Newcomer, Oliver Werz
Summary: This study reveals that 3-O-acetyl-11-keto-beta-boswellic acid (AKBA) can activate cellular 15-LOX-1 and promote the formation of specialized pro-resolving mediators (SPM) for inflammation resolution. AKBA-induced LOX activation is independent of calcium and phosphorylation, with modest induction of 5-LOX products. The docking of AKBA with the R98 site of 15-LOX-1 is essential for its allosteric activation.
Article
Pharmacology & Pharmacy
Tran Thi Van Anh, Alilou Mostafa, Zhigang Rao, Simona Pace, Stefan Schwaiger, Christian Kretzer, Veronika Temml, Carsten Giesel, Paul M. Jordan, Rossella Bilancia, Christina Weinigel, Silke Rummler, Birgit Waltenberger, Tran Hung, Antonietta Rossi, Hermann Stuppner, Oliver Werz, Andreas Koeberle
Summary: The study identified a potential drug candidate from Vietnamese medicinal plant extracts to alleviate chronic inflammation by targeting 5-lipoxygenase and switching the lipid mediator profile. This candidate showed promising activity in inhibiting leukotriene production and inducing specialized pro-resolving mediators, offering a new strategy to address chronic inflammatory conditions.
ACTA PHARMACEUTICA SINICA B
(2021)
Article
Immunology
Laura Miek, Paul M. Jordan, Kerstin Guenther, Simona Pace, Timo Beyer, David Kowalak, Verena Hoerr, Bettina Loeffler, Lorena Tuchscherr, Charles N. Serhan, Jana Gerstmeier, Oliver Werz
Summary: The study reveals that S. aureus infection can modulate lipid mediator pathways involved in inflammatory processes, resulting in a shift from anti-inflammatory M2-like signature profiles to pro-inflammatory M1-like signature profiles.
Review
Immunology
Arista Nienaber, Frank E. A. Hayford, Ebrahim Variava, Neil Martinson, Linda Malan
Summary: Host-directed therapies aim to enhance the host response to TB infection, with NSAIDs and n-3 LCPUFA being examples of such therapies that reduce disease severity by modulating the immune response. These therapies have shown promising effects in pre-clinical studies, but further clinical trials are needed to confirm their benefits and safety in TB patients, especially during later stages of infection.
FRONTIERS IN IMMUNOLOGY
(2021)
Article
Pharmacology & Pharmacy
Jesper Safholm, Willem Abma, Jielu Liu, David Balgoma, Alexander Fauland, Johan Kolmert, Craig E. Wheelock, Mikael Adner, Sven-Erik Dahlen
Summary: The study revealed the mechanism by which COX inhibition increases antigen-induced responses in airways. Challenge with OVA increased the release of prostaglandins and thromboxanes, and COX inhibition resulted in increased release of mast cell mediators and enhanced bronchoconstriction.
EUROPEAN JOURNAL OF PHARMACOLOGY
(2021)
Review
Pharmacology & Pharmacy
Zhigang Rao, Diego Caprioglio, Andre Gollowitzer, Christian Kretzer, Daniela Imperio, Juan A. Collado, Lorenz Waltl, Sandra Lackner, Giovanni Appendino, Eduardo Munoz, Veronika Temml, Oliver Werz, Alberto Minassi, Andreas Koeberle
Summary: This study investigates the inhibitory effects of curcuminoid analogues on 5-LOX and mPGES-1, leading to the identification of potent and selective inhibitors for these enzymes.
BIOCHEMICAL PHARMACOLOGY
(2022)
Article
Cell Biology
Maria Eduarda Ziani Gutierrez, Anne Suely Pinto Savall, Edina Luz Abreu, Kelly Ayumi Nakama, Renata Bem Dos Santos, Marina Costa Monteiro Guedes, Daiana Silva Avila, Cristiane Luchese, Sandra Elisa Haas, Caroline Brandao Quines, Simone Pinton
Summary: Inflammation plays a role in the development and progression of Alzheimer's disease, and meloxicam and curcumin can improve memory impairment induced by amyloid-beta peptide by inhibiting COX-2.
NEURAL REGENERATION RESEARCH
(2021)
Article
Biochemistry & Molecular Biology
Alexia Perryman, Adam M. Speen, Hye-Young H. Kim, Jessica R. Hoffman, Phillip W. Clapp, William Rivera Martin, John N. Snouwaert, Beverly H. Koller, Ned A. Porter, Ilona Jaspers
Summary: The study reveals that SecoA generated by ozone oxidation of lipid in the air modifies multiple proteins, among which NLRP2 in bronchial epithelial cells is identified. It is found that NLRP2 plays a negative regulatory role in modulating inflammation induced by O-3.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY
(2021)
Article
Cell Biology
Jingjing Tian, Yihui Du, Ermeng Yu, Caixia Lei, Yun Xia, Peng Jiang, Hongyan Li, Kai Zhang, Zhifei Li, Wangbao Gong, Jun Xie, Guangjun Wang
Summary: This study found that the COX pathway is involved in lipid degradation induced by energy deprivation, and that PGF2 alpha is a key molecule triggering autophagy, lipolysis, and mitochondrial development in zebrafish hepatocytes.
Article
Environmental Sciences
Xiaoling Liu, Chunyan Yao, Yan Tang, Xiaoyan Liu, Chenggang Duan, Chunmei Wang, Fei Han, Ying Xiang, Long Wu, Yafei Li, Ailing Ji, Tongjian Cai
Summary: Excessive exposure to manganese may lead to neuroinflammation, and it can inhibit the expression of p53 through DNA methylation, further inducing the expression of COX-2 in microglial cells.
ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY
(2022)
Article
Immunology
Subulade A. Ademola, Oluwayemi J. Bamikole, Olukemi K. Amodu
Summary: Malaria remains a global public health issue, particularly in sub-Saharan Africa. The number of malaria deaths decreased steadily from 2000 to 2019, but there was an increase of 10% in 2020 due to disruptions caused by the COVID-19 pandemic. Four countries, namely Nigeria, the Democratic Republic of the Congo, Niger, and Tanzania, accounted for over half of the malaria deaths globally. Nigeria has the highest burden of diabetes in Africa, with a prevalence of 5.77%. Studies have shown an interaction between malaria and type 2 diabetes (T2D), with malaria infection in pregnancy potentially leading to low birth weight and an increased risk of T2D later in life. Inflammation, particularly involving tumor necrosis factor alpha (TNF-a), plays a crucial role in the co-existence of malaria and T2D.
FRONTIERS IN IMMUNOLOGY
(2023)
Article
Medicine, Research & Experimental
Zhiguo Wu, Yuchan Wu, Weicheng Zhong, Qingmei Zhong, Shengfang Rao, Dongshan Yu, Xiaolu Luo, Fang Qiu, Zhiying Song, Di Jin, Maoxing Ai, Yu Lan, Gongchang Zhang, Shufeng Song, Baogang Xie, Shuilin Sun
Summary: Aspirin can reduce liver fibrosis index and inflammation levels, but the mechanism behind its effects is still unclear. This study aimed to investigate the protective effects of aspirin on carbon tetrachloride (CCl4)-induced hepatic fibrosis in Sprague-Dawley rats. The rats were divided into four groups, including healthy and CCl4 control groups, and low- and high-dose aspirin groups. After 8 weeks of treatment, histopathological examinations and serum measurements were conducted to assess fibrosis and inflammation. The results showed that aspirin decreased CCl4-induced hepatic fibrosis and liver inflammation. The high-dose aspirin group exhibited significant reductions in serum levels of ALT, AST, HA, and LN, as well as pro-inflammatory cytokine IL-1 beta. Furthermore, aspirin inhibited the expression of TGF beta-1 protein. Overall, this study suggests that aspirin has potent protective effects against CCl4-induced hepatic fibrosis by inhibiting the TGF beta-1 pathway and IL-1 beta.
EXPERIMENTAL AND THERAPEUTIC MEDICINE
(2023)
Article
Chemistry, Medicinal
Murat Bozdag, Tobias Dreker, Christophe Henry, Paolo Tosco, Maura Vallaro, Roberta Fruttero, Andrea Scozzafava, Fabrizio Carta, Claudiu T. Supuran
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
(2013)
Article
Chemistry, Multidisciplinary
Alessandro Barge, Marina Caporaso, Giancarlo Cravotto, Katia Martina, Paolo Tosco, Silvio Aime, Carla Carrera, Eliana Gianolio, Giorgio Pariani, Davide Corpillo
CHEMISTRY-A EUROPEAN JOURNAL
(2013)
Article
Chemistry, Medicinal
Marco L. Lolli, Marta Giorgis, Paolo Tosco, Antonio Foti, Roberta Fruttero, Alberto Gasco
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
(2012)
Article
Chemistry, Medicinal
Donatella Boschi, Paolo Tosco, Naveen Chandra, Shilpi Chaurasia, Roberta Fruttero, Roger Griffin, Lan-Zhen Wang, Alberto Gasco
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
(2013)
Article
Chemistry, Medicinal
Paolo Tosco, Thomas Balle
JOURNAL OF CHEMICAL INFORMATION AND MODELING
(2012)
Article
Chemistry, Medicinal
Andreas Klamt, Michael Thormann, Karin Wichmann, Paolo Tosco
JOURNAL OF CHEMICAL INFORMATION AND MODELING
(2012)
Article
Biochemistry & Molecular Biology
Paolo Tosco, Thomas Balle, Fereshteh Shiri
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN
(2011)
Article
Biochemistry & Molecular Biology
Paolo Tosco, Thomas Balle
JOURNAL OF MOLECULAR MODELING
(2011)
Article
Biochemistry & Molecular Biology
Paolo Tosco, Thomas Balle, Fereshteh Shiri
JOURNAL OF MOLECULAR MODELING
(2011)
Article
Biochemistry & Molecular Biology
Silvia Bonomo, Paolo Tosco, Marta Giorgis, Marco Lolli, Roberta Fruttero
JOURNAL OF MOLECULAR MODELING
(2013)
Article
Biochemistry & Molecular Biology
Antonia Patruno, Paolo Tosco, Emily Borretto, Sara Franceschelli, Paolo Amerio, Mirko Pesce, Stefano Guglielmo, Pietro Campiglia, Maria Grazia Bernengo, Roberta Fruttero
NITRIC OXIDE-BIOLOGY AND CHEMISTRY
(2012)
Article
Chemistry, Multidisciplinary
Paolo Tosco, Nikolaus Stiefl, Gregory Landrum
JOURNAL OF CHEMINFORMATICS
(2014)
Article
Chemistry, Medicinal
Maximilian Kuhn, Stuart Firth-Clark, Paolo Tosco, Antonia S. J. S. Mey, Mark Mackey, Julien Michel
JOURNAL OF CHEMICAL INFORMATION AND MODELING
(2020)
Article
Chemistry, Medicinal
Jenke Scheen, Wilson Wu, Antonia S. J. S. Mey, Paolo Tosco, Mark Mackey, Julien Michel
JOURNAL OF CHEMICAL INFORMATION AND MODELING
(2020)